Ali, M.A.; Anwar, M.Y.; Aiman, W.; Dhanesar, G.; Omar, Z.; Hamza, M.; Zafar, M.; Rengarajan, H.K.; Maroules, M.
Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials. J. Xenobiot. 2023, 13, 29-41.
https://doi.org/10.3390/jox13010005
AMA Style
Ali MA, Anwar MY, Aiman W, Dhanesar G, Omar Z, Hamza M, Zafar M, Rengarajan HK, Maroules M.
Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials. Journal of Xenobiotics. 2023; 13(1):29-41.
https://doi.org/10.3390/jox13010005
Chicago/Turabian Style
Ali, Muhammad Ashar, Muhammad Yasir Anwar, Wajeeha Aiman, Gurneel Dhanesar, Zainab Omar, Mohammad Hamza, Maha Zafar, Harish Kumar Rengarajan, and Michael Maroules.
2023. "Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials" Journal of Xenobiotics 13, no. 1: 29-41.
https://doi.org/10.3390/jox13010005
APA Style
Ali, M. A., Anwar, M. Y., Aiman, W., Dhanesar, G., Omar, Z., Hamza, M., Zafar, M., Rengarajan, H. K., & Maroules, M.
(2023). Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials. Journal of Xenobiotics, 13(1), 29-41.
https://doi.org/10.3390/jox13010005